艾媒咨询 | 2025年中国月子中心消费者行为调查数据

近年来，随着消费者对科学坐月子理念的认知提升，二、三线城市月子中心市场也迅速崛起，市场规模持续扩大，服务品质和管理水平不断提升。根据全球新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国月子中心消费者行为调查数据》数据显示，在 2025 年针对中国消费者对月子中心的了解情况调研中，高达 87.41% 的消费者明确表示知晓月子中心，这一占比在各项反馈中居于首位，清晰地彰显出月子中心于中国消费者群体里已具备较高的普及程度。而在消费者对月子中心服务的关注点方面，对宝宝的专业照护以 37.65% 的占比拔得头筹，这一数据直观且有力地表明，消费者最为看重月子中心在照料宝宝方面所展现出的质量 。艾媒咨询分析师认为，随着政府对月子中心行业监管力度的加强，行业规范化发展将成为必然趋势。未来，政府将出台更加严格的行业标准和规范，加强对月子中心的审批、监管和评估，推动月子中心行业健康、有序发展。同时，行业协会将发挥更大作用，加强行业自律，促进企业之间的交流与合作，共同提升行业整体服务水平。
In recent years, with the improvement of consumers' awareness of the concept of scientific confinement, the central market of the second and third-tier cities has also risen rapidly, the market size has continued to expand, and the service quality and management level have continued to improve. According to the latest "Data from the China month center consumer behavior survey in 2025" released by iiMedia Research, a third party data mining and analysis institution in the global new economy industry, according to the data, in 2025, the understanding of Chinese consumers about maternity centers is investigated. Up to 87.41% of consumers clearly know the maternity center, which ranks first in the feedback, clearly showing that the maternity center has a high degree of popularity in the Chinese consumer group. In terms of consumers' focus on maternity center services, professional care for babies topped the list with 37.65%, which intuitively and strongly indicates that consumers value the quality of maternity center care for babies the most. Ai Media Consulting analysts believe that with the strengthening of the government's supervision of the maternity center industry, the standardized development of the industry will become an inevitable trend. In the future, the government will introduce more stringent industry standards and norms, strengthen the approval, supervision and evaluation of the maternity center, and promote the healthy and orderly development of the maternity center industry. At the same time, the industry association will play a greater role in strengthening industry self-discipline, promoting exchanges and cooperation between enterprises, and jointly improving the overall service level of the industry.

复旦张江2021年第三季度报告

复星医药2021年第三季度报告

上海复旦复华科技股份有限公司2021年第三季度报告

艾媒咨询｜2021年11-12月中国母婴行业运行数据监测双月报

随着三孩政策以及人们生活水平的提高，中国母婴市场有着较大的拓展和发展空间。数据显示，2018年到2021年，中国母婴市场规模呈现上升趋势，截止到2021年12月，中国母婴市场规模为4.9万亿元，同比增长率为19.5%。预计在接下来的三年，中国母婴市场规模继续上升，到2024年中国母婴市场规模，预计达到7.6万亿元。

复旦微电2021年第三季度报告

海源复材：2021年第三季度报告

艾媒报告 |2019中国月子中心运行大数据与产业趋势分析报告

本报告研究涉及企业/品牌/案例：轻松妈妈，58月嫂，喜喜母婴，有福妈妈，奶牛妈妈，菩提果，贝瑞佳母婴，妈妈派育儿，蜜月佳，栗子孕育，仕馨月子会所，喜之家，爱帝宫，馨月汇，优艾贝，悦子阁，知爱，巍阁月子会所

月子中心，成为一种为产妇和婴儿提供专业服务的新型业态。艾媒商情舆情数据监测系统显示，2019年，中国的月子中心大多分布于一二线城市，用户最关注服务质量（如豪华套房）、宝宝护理和产后修复等话题。目前，月子中心主要采用酒店服务式、医院附属式、社区家庭式的运营模式，资本投入相对活跃。然而，艾媒咨询分析师认为，从业人员素质不高、价格较高和行业监管尚未成熟，仍是业态弊端。

Moon Center has become a new type of professional service for mothers and babies. According to the monitoring system of commercial and public opinion data of Ai Media, in 2019, most of China's Yuezi centers are located in the second-tier cities, and users are most concerned about the topics of service quality (such as luxury suites), baby care and post-natal rehabilitation. At present, Yuezi Center mainly adopts hotel service mode, Hospital Affiliated mode and community family mode of operation, with relatively active capital investment. However, Ai Media Consulting Analysts believe that the quality of employees is not high, the price is high and the industry supervision is not yet mature, which is still a shortcoming of the industry.

复洁环保:2021年第三季度报告

艾媒报告 |2019年中国生物医药产业发展及舆论焦点分析报告

本报告研究涉及企业/品牌包括:Takeda、GSK、Sanofi、Celgene、Novartis、宝洁、CVC Fund VII、Shire、诺华OTC、Bioverativ、Juno Therapeutics、AveXis、Impact Biomedicines、Tesaro、Ablynx、默克OTC、Recordati控股公司FIMEI、复星医药、海正药业、康弘药业、泰合健康、齐鲁制药、复宏汉霖、信达生物、张江生物、恒瑞医药、三生国健、嘉和生物、百奥泰、深圳龙瑞、天坛生物、华兰生物、博雅生物、上海莱士、卫光生物、辽宁成大、智飞生物、康泰生物、沃森生物、利德曼、交大昂立、华润双鹤、力生制药、海欣股份、联环药业、白云山、中源协和、普洛药业

随着生物医药技术不断突破，中国生物医药产业快速发展，2018年，单抗、血液制品、疫苗等生物医药相关领域多家头部上市企业营收均超亿元，实现同比增长。iiMedia Research(艾媒咨询)监测发现，生物医药产业网络言值指数为49.7，网民评价态度偏向正面，上海网民对生物医药产业的关注度最高。未来，随着中国生物医药行业上市公司数量增多，行业与企业间竞争将更加激烈。

The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry.